Belinda Kingston
Overview
Explore the profile of Belinda Kingston including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kingston B, Pearson A, Herrera-Abreu M, Sim L, Cutts R, Shah H, et al.
Cancer Discov
. 2023 Nov;
14(2):274-289.
PMID: 37982575
Significance: Novel F404 ESR1 mutations may be acquired to cause overt resistance to fulvestrant when combined with preexisting activating ESR1 mutations. Novel combinations of mutations in the ER ligand binding...
2.
Kingston B, Cutts R, Bye H, Beaney M, Walsh-Crestani G, Hrebien S, et al.
Nat Commun
. 2021 Jul;
12(1):4479.
PMID: 34272402
No abstract available.
3.
Kingston B, Cutts R, Bye H, Beaney M, Walsh-Crestani G, Hrebien S, et al.
Nat Commun
. 2021 Apr;
12(1):2423.
PMID: 33893289
The genomics of advanced breast cancer (ABC) has been described through tumour tissue biopsy sequencing, although these approaches are limited by geographical and temporal heterogeneity. Here we use plasma circulating...
4.
Kingston B, Bailleux C, Delaloge S, Schiavon G, Scott V, Lacroix-Triki M, et al.
JCO Precis Oncol
. 2020 Sep;
3.
PMID: 32923864
No abstract available.
5.
Turner N, Kingston B, Kilburn L, Kernaghan S, Wardley A, Macpherson I, et al.
Lancet Oncol
. 2020 Sep;
21(10):1296-1308.
PMID: 32919527
Background: Circulating tumour DNA (ctDNA) testing might provide a current assessment of the genomic profile of advanced cancer, without the need to repeat tumour biopsy. We aimed to assess the...
6.
Pearson A, Proszek P, Pascual J, Fribbens C, Shamsher M, Kingston B, et al.
Clin Cancer Res
. 2019 Oct;
26(3):608-622.
PMID: 31591187
Purpose: Advanced breast cancer (ABC) has not been subjected to the same degree of molecular scrutiny as early primary cancer. Breast cancer evolves with time and under the selective pressure...
7.
Battisti N, Kingston B, King J, Denton A, Waters S, Sita-Lumsden A, et al.
Breast Cancer Res Treat
. 2019 Jan;
174(3):731-740.
PMID: 30656459
Purpose: Palbociclib is approved in 1st line for hormone receptor (HR)-positive HER2-negative advanced breast cancer (ABC). A Compassionate Access Programme previously allowed patients to receive it in 4th line. However,...
8.
Kingston B, Kayhanian H, Brooks C, Cox N, Chaabouni N, Redana S, et al.
Breast
. 2017 Oct;
36:54-59.
PMID: 28968585
Purpose: Leptomeningeal disease (LMD) is an uncommon complication of advanced breast cancer. The prognosis is poor, and although radiotherapy (RT), systemic and intra-thecal (IT) chemotherapy are accepted treatment modalities, efficacy...